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associated diarrhea (CDAD) have recently increased
worldwide and correlate with the dissemination of
hypervirulent C. difficile polymerase chain reaction (PCR)
ribotype 027.1
A 75-year-old man was diagnosed with squamous car-
cinoma of the esophagus in April 2014. A complex episode
of cytomegalovirus and bacterial infection with septic
shock occurred during the period of combined chemo-
radiotherapy. The patient initially received the antiviral
agent ganciclovir (600 mg/d) and Tapimycin (piperacillin
12 g/d and tazobactam 1500 mg/d) for 4 days. The
treatment regimen was then changed to teicoplanin
(1300 mg/d) and cefepime (4000 mg/d) for 10 days. After
recovery from sepsis, diarrhea, fever, and abdominal pain
developed and persisted for 14 days. Colonoscopic exam-
ination results revealed broadly diffused yellow-white
exudates and pseudomembrane on the colon mucosa.
The DUO TOXIN AþB assay (VEDALAB, Alenc¸on, France)
presented a positive result for the stool sample. TheConflicts of interest: The authors have no conflicts of interest
relevant to this article.
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CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-ndCepheid Xpert C. difficile Epi assay (Cepheid, Sunnyvale,
CA) identified a hypervirulent strain 027 of C. difficile.
The causative agent was anaerobically isolated on cyclo-
serineecefoxitinefructose agar medium. Both the original
stool sample and the isolated agent were sent to the
Cepheid Company for further confirmation by PCR ribo-
typing and compared with a set of type strains from the
Cardiff ribotype collection. The patient’s diarrhea
stopped after treatment with intravenous vancomycin
(600 mg/d) for 5 days and oral metronidazole (1500 mg/d)
for 25 days. The patient received combined chemo-
radiotherapy continuously and remained in stable
condition.
Several prospective surveys of C. difficile had been
performed in Taiwan in the past 10 years (Table 1).1,2,4,5
The incidences of CDAD decreased from 1.0/1000 patient-
days in 2003 to 0.426/1000 patient-days in recent years.1
The hypervirulent ribotype 027 strain has not been
observed in Taiwan. However, 13 toxigenic C. difficile iso-
lates from CDAD patients were analyzed using PCR ribo-
typing in two previous studies.1,2 Because academic
methods for typing C. difficile isolates displayed some
discordant results,3 we used the Xpert C. difficile Epi test
instead to directly detect the pathogen on stool samples of
CDAD patients and provided presumptive evidence of type
027/NAP1/BI in a prospective study at the Tri-Service
General Hospital (IRB_1-102-05-096) since August 2013.
Only nine CDAD cases that fulfilled the clinical inclusionby Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
Table 1 Previous studies on the Clostridium difficile prevalence and infections in Taiwan.
Study year Location Publication Population Study type CD
isolatesa
Toxigenic
strainsb
CDAD
casesc
Colonization
rate
CDAD
incidence
Ribotyped
CDAD
isolatesd
Study
2003 Northern
Taiwan
2006 Journal of Microbiology,
Immunology and Infection
48
in-patients
3-M
Prospective
11 4 4 ND 1/1000
patient-days
0 Wei et al1
2007e2008 Southern
Taiwan
2010 Journal of Microbiology,
Immunology and Infection
86
medical
records
14-M
Retrospective
ND ND 86 ND 0.43/1000
patient-days
0 Wei et al1
2009 Taichung 2013 Journal of Microbiology,
Immunology and Infection
149
residents in
six RCWs
Prospective 57 29 6 0.19 4% 6 Wei et al1
2010 Northern
Taiwan
2012 Journal of Microbiology,
Immunology and Infection
80
in-patients
5-M
Prospective
14 25 25 ND 0.45/1000
patient-days
0 Wei et al1
2011 Southern
Taiwan
2012 PLoS One 168
in-patients
6-M
Prospective
37 26 7 ND 4.20% 7 Hung et al2
2005e2010 Nation
wide
2012 Antimicrobial Agents and
Chemotherapy
403
collections
Retrospective 403 233 ND ND ND 0 Liao et al4
2011e2012 Southern
Taiwan
2013 PLoS One 441
in-patients
15-M
Prospective
84 58 8 ND 0.46/1000
patient-days
0 Hung et al5
CD Z Clostridium difficile; CDAD Z C. difficile-associated diarrhea; ND Z not detected; RCW Z respiratory care ward.
a A total of 203 isolates from five prospective clinical surveys.
b A total of 142 toxigenic strains were approved by the toxin enzyme immunoassay.
c A total of 55 toxigenic isolates were collected in the prospective clinical surveys.
d A total of 13 toxigenic isolates from CDAD cases were ribotyped.
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212 M.-J. Lai et al.criteria and were positive for DUO TOXIN AþB assay were
tested in 1 year. Six stool samples were confirmed to be
toxigenic due to being positive for the toxin B gene (tcdB)
and the binary toxin gene (cdt) in the Xpert C. difficile Epi
tests. One of these was presumably identified as PCR
ribotype 027 with detection of the tcdC gene deletion at
nucleotide 117.
We described the first CDAD case of C. difficile ribotype
027 in Taiwan from an esophageal cancer patient who
received concurrent chemoradiotherapy. Because the
hypervirulent 027 ribotype is present in Taiwan, accurate
and rapid diagnosis of toxigenic strains of C. difficile is
therefore essential for optimal patient care and to prevent
hospital spread of the infection.
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